Z-0918-2021 Class II Terminated

Recalled by Fujifilm Medical Systems U.S.A., Inc. — Lexington, MA

FDA device recall Z-0918-2021 was initiated by Fujifilm Medical Systems U.S.A., Inc. on December 11, 2020 and is designated Class II. Reason for recall: The software does not update measurements and calculations in the Clinical Reporting Application (CRA) when the ventricular trace is changed in the study by a different user. The recall status is terminated (terminated November 17, 2021). Affected quantity: 1 unit.

Recall Details

Product Type
Devices
Report Date
February 3, 2021
Initiation Date
December 11, 2020
Termination Date
November 17, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1 unit

Product Description

FUJIFILM Synapse PACS Software: versions 7.0.0 and 7.0.1 - Product Usage: intended for use as a web based application on an off-the shelf PC which meets or exceeds minimum specifications and is networked with a FUJIFILM Synapse PACS server.

Reason for Recall

The software does not update measurements and calculations in the Clinical Reporting Application (CRA) when the ventricular trace is changed in the study by a different user.

Distribution Pattern

US Nationwide distribution in the state of MD.

Code Information

Versions 7.0.0 and 7.0.1